Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Cytotherapy|September 21, 2017
Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplantGaurav Sutrave, Emily Blyth, David J GottliebCurrent Opinion in Oncology|October 9, 2019
Adoptive cell therapies for posttransplant infectionsGaurav Sutrave, David J GottliebReviews in Medical Virology|March 31, 2026
Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR-T Cell Recipients-PART 2: Antiviral Therapy and Virus-Specific T Cell Therapy for HCMV in Allo-HSCTGaurav Sutrave, Michelle K Yong, Danya Kaplan, et al.Reviews in Medical Virology|April 15, 2026
Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR T Cell Recipients - PART 1: Risk Factors, Clinical Impact and Immune ResponseDanya Kaplan, Emily Blyth, Gaurav Sutrave, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 25, 2020
Successful treatment of CMV, EBV, and adenovirus tissue infection following HLA-mismatched allogeneic stem cell transplant using infusion of third-party T cells from multiple donors in addition to antivirals, rituximab, and surgeryPietro R Di Ciaccio, Selmir Avdic, Gaurav Sutrave, et al.Current Hematologic Malignancy Reports|June 23, 2019
Pathogen-Specific T Cells Beyond CMV, EBV and AdenovirusWei Jiang, Barbara Withers, Gaurav Sutrave, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 15, 2015
A fatal case of acute HHV-6 myocarditis following allogeneic haemopoietic stem cell transplantationYvonne Brennan, David J Gottlieb, David Baewer, et al.American Journal of Hematology|May 13, 2022
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplantDavid J Gottlieb, Gaurav Sutrave, Wei Jiang, et al.Cytotherapy|August 8, 2012
Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatusShivashni S Gaundar, Leighton Clancy, Emily Blyth, et al.Molecular Therapy. Methods & Clinical Development|April 27, 2022
Characterizing piggyBat-a transposase for genetic modification of T cellsGaurav Sutrave, Ning Xu, Tiffany C Y Tang, et al.Pageof 10